MoneyWorks4Me

Lupin informs about earnings call

28 Oct 2022 Evaluate

Pursuant to Regulation 30(2) read with Schedule III Part A (15) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, Lupin has informed that Earnings Call for Quarter - II, FY 2023 (invite copy enclosed) is scheduled on Thursday, November 10, 2022 at 16.00 hrs (IST). Transcripts of the said Call will be filed electronically with the exchange pursuant to the aforesaid Regulations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..